| Document |
Document Title |
|
WO/2024/086700A1 |
Methods and devices are provided for capturing and using quantitative and qualitative results from point-of- collection devices for different diagnostic assays on a mobile device application. In one nonlimiting embodiment, these methods ...
|
|
WO/2024/086159A1 |
This disclosure relates to methods and compositions for quantitative risk assessment of lesions in the oral cavity. The risk assessment tools can be used at point of care facilities. This disclosure provides methods and compositions for ...
|
|
WO/2024/086493A1 |
The presently disclosed subject matter relates to an in vitro method for the diagnosis or follow-up of an inflammatory disorder in a Felidae. The presently disclosed subject matter also relates to compounds, and compositions thereof, for...
|
|
WO/2024/082581A1 |
The present invention relates to the field of biomedicine, and in particular, to an M protein detection method. The method comprises: 1) providing m/z distribution data of singly-charged ions in immunoglobulin light chains in samples to ...
|
|
WO/2024/084470A1 |
A method of imaging a biological sample is disclosed, which comprises coupling at least one affinity probe to the biological sample, wherein the affinity probe includes a cleavable tag, bringing the probe-coupled biological sample into c...
|
|
WO/2024/083822A1 |
In a first aspect the invention relates to a method for identifying a subject suffering from Alzheimer's dementia (AD) or being at risk of developing Alzheimer's dementia, the method comprising: (a) determining in a first body fluid samp...
|
|
WO/2023/196642A9 |
Novel approaches for processing polymeric analytes, such as biopolymers, are provided herein. A method for processing a polymeric analyte may comprise coupling a monomer of the polymeric analyte to a capture moiety, cleaving the monomer ...
|
|
WO/2024/086829A1 |
Disclosed are various embodiments of a device comprising a synthetic polymeric substrate having a high quality finish upper surface, the upper surface having at least a bilayer coating comprising a first, reflective layer and a second, t...
|
|
WO/2024/084719A1 |
[Problem] To manage menstruation more simply and efficiently. [Solution] A method according to the present disclosure comprises, by a processor, obtaining information relating to wearing of water-absorbing shorts, obtaining, by a menstru...
|
|
WO/2024/082229A1 |
The present application is applicable to the field of medical apparatuses, and discloses a microfluidic chip and a microfluidic analysis system. The microfluidic chip comprises a non-circular chip body, wherein a sample injection cavity,...
|
|
WO/2024/084281A1 |
The present invention relates to compositions and non-invasive methods for detecting cell death by detecting beta cell genomic DNA in a urine sample. The invention relates the discovery that the presence of hypomethylated beta cell DNA o...
|
|
WO/2024/084250A1 |
The present invention provides a method of stratifying test subjects with Polycystic Ovary Syndrome (PCOS) into those that are expected to respond to therapeutic treatment with an inhibitor of hypothalamic-pituitary-adrenal axis activity...
|
|
WO/2024/084264A1 |
An immunoassay method for detecting an amount of host cell proteins (HCPs) comprising forming a plurality of HCP-immobilized antibody complexes by contacting the sample with a surface comprising a plurality of immobilized polyclonal anti...
|
|
WO/2024/083429A1 |
The present invention provides an antimicrobial agent for use in the treatment or prevention of a bacterial infection, wherein a patient is selected for treatment using the antimicrobial agent based on the level of D-lactate in a patient...
|
|
WO/2024/082178A1 |
Provided is a chimeric antigen receptor, comprising a first antigen-binding domain and a second antigen-binding domain, wherein the first antigen-binding domain targets CD19, and the second antigen-binding domain targets CD22. Also provi...
|
|
WO/2024/085195A1 |
Provided is an examination method for irAE enteritis, said examination method comprising a detection step for detecting, as an indicator of ulcerous colitis-like irAE enteritis, an antibody that immunologically reacts with a fragment of,...
|
|
WO/2024/084807A1 |
Provided is a method for assaying fibroblast growth factor 18 (FGF18), whereby FGF18 can be detected/assayed with specificity. In the present invention, fibroblast growth factor 18 (FGF18) in a sample is assayed using a first antibody ...
|
|
WO/2024/083285A1 |
The present disclosure relates to a serological test for detection of anti-HPV antibodies. The serological test uses antigens having a linear epitope which is reactive and is such that multiple or many antibodies, each of which is effect...
|
|
WO/2024/085698A1 |
The present invention provides a pharmaceutical composition for the prevention or treatment of inflammatory bowel disease, comprising a glycogen phosphorylase (PYGL) inhibitor as an active ingredient, and a method for screening for a mat...
|
|
WO/2024/082054A1 |
Methods, kits and devices for detecting pepsinogen A4 (PGA4), and optionally bile acid (BA), in lungs such as transplant recipient lungs for assessing gastric aspiration and/or likelihood of developing an adverse outcome for the recipien...
|
|
WO/2024/084424A1 |
The invention concerns an apparatus (100) for monitoring a health status of a tree (TR) comprising sensors (10A, 10B) configured to perform measurements of parameters indicative of the health status of the tree (TR) and a processing syst...
|
|
WO/2024/084458A1 |
The present disclosure relates to a method, assays for assessing TKI compliance and disease progression despite treatment in a subject. The present disclosure also relates to a combination of biological markers employed in the method for...
|
|
WO/2024/085421A1 |
A sensing device is disclosed. In particular, a sensing device according to the present disclosure comprises: a concentration unit that concentrates an analyte contained in a sample; and a sensing unit that detects the type of the analyt...
|
|
WO/2024/085447A1 |
The present invention relates to a biomarker for liver cancer diagnosis and an artificial intelligence-based method for providing information for liver cancer diagnosis. More specifically, the present invention relates to a biomarker com...
|
|
WO/2024/082992A1 |
The present invention relates to an apparatus for the body fluid based detection of chronic diseases, and belongs to the technical field of medical instruments. The apparatus comprises a body fluid detection fluid channel, a detection pr...
|
|
WO/2024/083973A1 |
The present invention relates to a host cell. The host cell finds utility as a biosensor by comprising at least one nucleic acid modification in the nucleic acid sequence of at least one gene. Also disclosed is the host cell for use as a...
|
|
WO/2024/086512A1 |
Methods and systems for analyzing lipid nanoparticles using size exclusion chromatograph coupled with multi angle light scattering are disclosed.
|
|
WO/2024/082026A1 |
The present invention provides methods for the detection of aggressive prostate cancer by reference to levels of WAP four-disulfide core domain 2 protein, particularly by comparison to a mixed control population of subjects with non-aggr...
|
|
WO/2024/082410A1 |
A method for evaluating shale occurrence oil and a method for evaluating the geological exploitable reserve of shale oil. The method for evaluating shale occurrence oil comprises: acquiring a powder sample of a target shale core; extract...
|
|
WO/2024/082053A1 |
A system, method and apparatus to reconcile emissions measurement data with calculated emissions rates. A plume is constructed at each possible emissions source in which the emissions rate that generates the plume is sampled from a prior...
|
|
WO/2024/086373A1 |
Methods for diagnosing and trating Barrett's esophagus include the identification of biomarker panels.
|
|
WO/2024/082390A1 |
Provided is a use of a blood group antigen trisaccharide conjugate in blood group antibody detection, specifically, a use of a blood group antigen trisaccharide A analogue protein conjugate and a blood group antigen trisaccharide B analo...
|
|
WO/2023/049765A9 |
The current medical managements of CNS injuries, such as spinal cord injury (SCI), IO traumatic brain injury (TBI) or stroke are far from ideal. Clinical trials in acute CNS injuries are challenging because of multiple barriers, such as ...
|
|
WO/2024/086832A1 |
There is provided amino acid cleaving reagents with improved cleavage activity, allowing for more structural information to be obtained from polypeptides in sequencing reactions.
|
|
WO/2024/085722A1 |
The present invention relates to a biomarker for early diagnosis of kidney diseases, and use thereof. A composition, a kit and a method, according to one embodiment, enable kidney diseases or the risk of kidney diseases to be diagnosed a...
|
|
WO/2024/084726A1 |
The purpose of the present invention is to provide an absorbent article that enables a grasp of the appropriate period for trying to conceive at an earlier timing than before, and a test strip therefor. An absorbent article of the pres...
|
|
WO/2024/083104A1 |
A nucleic acid aptamer test strip, a preparation method therefor, and the use thereof, belonging to the technical field of pathogenic bacterium detection. The nucleic acid aptamer test strip comprises: a sample pad (1), a conjugate pad (...
|
|
WO/2024/086146A1 |
System, apparatus and method of testing a sample capable of transporting oxygen and including a dye, wherein the system includes: an illumination device to generate a first light pulse for a first period and second light pulses for each ...
|
|
WO/2024/083132A1 |
The present invention relates to a method for analyzing rock mass in virtue of the physical and chemical properties of the rock mass, in particular to a method for determining the metallogenic mechanism of hydrothermal uranium ore. The m...
|
|
WO/2024/084122A1 |
The present invention relates to the use of BODIPY-derived compounds to detect drugs such as scopolamine, ketamine and cathinones. When the chromophore BODIPY is combined with copper salts, its colour and fluorescence change in the prese...
|
|
WO/2024/085222A1 |
Provided is a method for detecting progranulin, said method being characterized by using: an antibody that is bounded specifically to the P domain or the G domain of progranulin; and an antibody that is bounded specifically to the E doma...
|
|
WO/2024/084211A1 |
A nanopore device and a method of controlling a nanopore device for analysing a polymer, the nanopore device comprising at least one sensor element, the sensor element comprising a nanopore and a sensor, the method comprising: translocat...
|
|
WO/2024/082024A1 |
The invention provides a method of detecting an extracellular analyte in a sample. In some examples, there is provided a method of detecting an extracellular analyte in a sample, comprising: providing a biosensor system selected from (i)...
|
|
WO/2024/085212A1 |
Biomarkers for human ALT1 and ALT2 and mouse ALT1 and ALT2, the biomarkers including a peptide for measuring human ALT1, a peptide for measuring human ALT2, a peptide for measuring mouse ALT1 and a peptide for measuring mouse ALT2; and a...
|
|
WO/2024/083185A1 |
The application relates to an isolated monoclonal antibody that specifically binds FGFR2B, or an antigen binding portion thereof. The application also relates to a nucleic acid molecule encoding the antibody or antigen binding portion th...
|
|
WO/2024/083499A1 |
The invention relates to a device (1) for determining the diffusion coefficient of a rock sample (2) under high-pressure conditions. The device (1) has a sample holder (3), having a sample receiving region (4) for receiving the rock samp...
|
|
WO/2024/085226A1 |
This detection kit has a target molecule detection device and a sealing liquid that is used in the detection device, the sealing liquid being a mixture of a lipophilic liquid and a surfactant, the concentration of the surfactant in the s...
|
|
WO/2024/086630A1 |
Methods of treating a subject with diabetes or Alzheimer's disease with a disclosed islet amyloid polypeptide (IAPP) isoform or peptide are provided. Methods of detecting IAPP isoforms or peptides are also provided.
|
|
WO/2024/084389A1 |
The present invention relates to a cell-free transcriptional electrochemical biosensor and to the use of the same for detecting specific molecular analytes, such as specific antibodies, proteins, small molecules, nucleic acids, and deriv...
|
|
WO/2024/085240A1 |
Provided is an absorbent article that can be used to more easily predict the day of ovulation as compared to conventional means. The absorbent article comprises a test strip that uses immunochromatography to detect the presence of lutein...
|
